Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-27

FDA Approved: PIMECROLIMUS — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves Actavis Pharma, Inc.'s original application for a generic pimecrolimus topical product. The product is indicated for the treatment of atopic dermat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimecrolimus (pimecrolimus)

Snippet

ORIG AP for PIMECROLIMUS (PIMECROLIMUS)